Lupus Science & Medicine: 7 (1)

Editorial

String of successful trials in SLE: have we cracked the code? (2 January, 2020)
Ronald van Vollenhoven

Animal models

Original research:
Targeting mitochondrial oxidative stress with MitoQ reduces NET formation and kidney disease in lupus-prone MRL-lpr mice
(16 April, 2020)
Karen A Fortner, Luz P Blanco, Iwona Buskiewicz, Nick Huang, Pamela C Gibson, Deborah L Cook, Hege L Pedersen, Peter S T Yuen, Michael P Murphy, Andras Perl, Mariana J Kaplan, Ralph C Budd

Brief communication

Efficacy and safety of rituximab biosimilar in refractory lupus (2 November, 2020)
Nantakarn Pongtarakulpanit, Prapaporn Pisitkun, Pintip Ngamjanyaporn
Effects of metformin on disease flares in patients with systemic lupus erythematosus: post hoc analyses from two randomised trials (22 October, 2020)
Fangfang Sun, Shikai Geng, Haiting Wang, Huijing Wang, Zhe Liu, Xiaodong Wang, Ting Li, Weiguo Wan, Liangjing Lu, Xiangyu Teng, Laurence Morel, Shuang Ye
Comparative analysis of long-term organ damage in patients with systemic lupus erythematosus using belimumab versus standard therapy: a post hoc longitudinal study (13 October, 2020)
Murray B Urowitz, Robert L Ohsfeldt, Ronald C Wielage, John J Dever, Mehdi Zakerifar, Yumi Asukai, Sulabha Ramachandran, Ashish V Joshi
Prevalence of progressive multifocal leukoencephalopathy (PML) in adults and children with systemic lupus erythematosus (7 June, 2020)
Teja Kapoor, Pooja Mahadeshwar, Joyce Hui-Yuen, Kayla Quinnies, Nicholas Tatonetti, Yevgeniya Gartshteyn, Cathy Guo, Laura Geraldino-Pardilla, Anca D Askanase
Cell-bound complement activation products associate with lupus severity in SLE (5 May, 2020)
Cristina Arriens, Roberta Vezza Alexander, Sonali Narain, Amit Saxena, Christopher E Collins, Daniel J Wallace, Elena Massarotti, John Conklin, Kenneth C Kalunian, Chaim Putterman, Rosalind Ramsey-Goldman, Jill P Buyon, Anca Askanase, Richard A Furie, Judith A James, Ghalib A Bello, Susan Manzi, Joseph Ahearn, Tyler O'Malley, Arthur Weinstein, Thierry Dervieux

Biomarker studies

Original research: Different indirect immunofluorescence ANA substrate performance in a diagnostic setting of patients with SLE and related disorders: retrospective review and analysis (5 November, 2020)
May Y Choi, Jing Cui, Karen Costenbader, David Rydzewski, Lisa Bernhard, Peter Schur
Original research: Evaluation of different ways to identify persistent positivity of lupus anticoagulant in systemic lupus erythematosus (2 November, 2020)
Michelle A Petri, Mertcan Avci, Laurence S Magder
Original research: Loss of antiphospholipid antibody positivity post-thrombosis in SLE (6 October, 2020)
Muznay Khawaja, Laurence Magder, Daniel Goldman, Michelle A Petri
Original research: Glycosphingolipid-associated β-1,4 galactosyltransferase is elevated in patients with systemic lupus erythematosus (13 July, 2020)
Vignesh Sadras, Michelle A Petri, Steven Richard Jones, Barbara Lee Peterlin, Subroto Chatterjee
Original research: Associations of serum soluble Fas and Fas ligand (FasL) with outcomes in systemic lupus erythematosus (15 June, 2020)
Fabien B Vincent, Rangi Kandane-Rathnayake, Rachel Koelmeyer, James Harris, Alberta Y Hoi, Fabienne Mackay, Eric F Morand

Clinical trials and drug discovery

Original research: Baricitinib-associated changes in global gene expression during a 24-week phase II clinical systemic lupus erythematosus trial implicates a mechanism of action through multiple immune-related pathways (9 October, 2020)
Thomas Dörner, Yoshiya Tanaka, Michelle A Petri, Josef S Smolen, Daniel J Wallace, Ernst R Dow, Richard E Higgs, Guilherme Rocha, Brenda Crowe, Robert J Benschop, Nicole L Byers, Maria E Silk, Stephanie de Bono, Damiano Fantini, Robert W Hoffman
Original research: Lupus patient decisions about clinical trial participation: a qualitative evaluation of perceptions, facilitators and barriers (15 March, 2020)
Cristina Arriens, Teresa Aberle, Fredonna Carthen, Stan Kamp, Aikaterini Thanou, Eliza Chakravarty, Judith A James, Joan T Merrill, Motolani E Ogunsanya

Cutaneous lupus

Original research: Robust measurement of clinical improvement in patients with cutaneous lupus erythematosus (27 January, 2020)
Benjamin A Nanes, Jane L Zhu, Benjamin F Chong

Co-morbidities

Original research: Associations of metabolic syndrome in SLE (13 November, 2020)
Diane Apostolopoulos, Fabien Vincent, Alberta Hoi, Eric Morand
Original research: Atherosclerosis in SLE: a potential role for serum parathormone levels (10 September, 2020)
Mayra Giannelou, Charalampos Skarlis, Aikaterini Stamouli, Eleni Antypa, Haralampos M Moutsopoulos, Clio P Mavragani
Original research: High-risk coronary plaque in SLE: low-attenuation non-calcified coronary plaque and positive remodelling index (28 July, 2020)
George Stojan, Jessica Li, Matthew Budoff, Armin Arbab-Zadeh, Michelle A Petri
Original research: Similar progression of carotid intima–media thickness in 7-year surveillance of patients with mild SLE and controls, but this progression is still promoted by dyslipidaemia, lower HDL levels, hypertension, history of lupus nephritis and a higher prednisolone usage in patients (9 January, 2020)
Sofia Ajeganova, Thomas Gustafsson, Linnea Lindberg, Ingiäld Hafström, Johan Frostegård

Dialogue

Learning to listen: how empathetic engagement with patients can help overcome reproductive injustice (23 November, 2020)
Megan E B Clowse

Epidemiology and outcomes

Original research: Corticosteroid dosing and opioid use are high in patients with SLE and remain elevated after belimumab initiation: a retrospective claims database analysis (23 December, 2020)
Julie A Birt, Jianmin Wu, Kirstin Griffing, Natalia Bello, Nicole Princic, Isabelle Winer, Carolyn R Lew, Karen H Costenbader
Original research: Rheumatologists’ perspective on hydroxychloroquine guidelines (3 November, 2020)
James Winebrake, Leila Khalili, Julia Weiner, Yevgeniya Gartshteyn, Lisa Park, Anca D Askanase
Original research: Evaluation of the LFA-REAL clinician-reported outcome (ClinRO) and patient-reported outcome (PRO): data from the Peruvian Almenara Lupus Cohort (12 October, 2020)
Manuel Francisco Ugarte-Gil, Rocio Violeta Gamboa-Cardenas, Cristina Reátegui-Sokolova, Victor Román Pimentel-Quiroz, Paola Zeña-Huancas, Claudia Elera-Fitzcarrald, Samira Garcia-Hirsh, Luciana Gil, Cesar Augusto Pastor-Asurza, Zoila Rodriguez-Bellido, Joan Merrill, Anca D Askanase, Graciela Alarcon, Risto Alfredo Perich-Campos
Original research: Cutaneous vasculitis in SLE (22 September, 2020)
Romy Kallas, Daniel Goldman, Michelle A Petri
Original research: Systemic lupus erythematosus and neutropaenia: a hallmark of haematological manifestations (2 July, 2020)
Aurore Meyer, Aurélien Guffroy, Gilles Blaison, Yannick Dieudonne, Zahir Amoura, Bernard Bonnotte, Christoph Fiehn, Pierre Kieffer, Hannes Martin Lorenz, Nadine Magy-Bertrand, François Maurier, Jean-Louis Pennaforte, Hans-Hartmut Peter, Andreas Schwarting, Jean Sibilia, Laurent Arnaud, Thierry Martin, Reinhard Edmund Voll, Anne-Sophie Korganow
Original research: Transition to severe phenotype in systemic lupus erythematosus initially presenting with non-severe disease: implications for the management of early disease (29 June, 2020)
Dionysis S Nikolopoulos, Myrto Kostopoulou, Antigoni Pieta, Sofia Flouda, Katerina Chavatza, Aggelos Banos, John Boletis, Pelagia Katsimbri, Dimitrios T Boumpas, Antonis Fanouriakis
Original research: Measurement properties of selected patient-reported outcome measures for use in randomised controlled trials in patients with systemic lupus erythematosus: a systematic review (25 June, 2020)
Vibeke Strand, Lee S Simon, Alexa Simon Meara, Zahi Touma
Original research: Disease duration, age at diagnosis and organ damage are important factors for cardiovascular disease in SLE (24 June, 2020)
Ola Nived, Ragnar Freyr Ingvarsson, Anna Jöud, Petrus Linge, Helena Tydén, Andreas Jönsen, Anders A Bengtsson
Original research: Overcoming barriers to recruitment and retention of African–American women with SLE in behavioural interventions: lessons learnt from the WELL study (11 June, 2020)
Cristina Drenkard, Kirk Easley, Gaobin Bao, Charmayne Dunlop-Thomas, S Sam Lim, Teresa Brady
Original research: High disease activity status suggests more severe disease and damage accrual in systemic lupus erythematosus (27 May, 2020)
Rachel Koelmeyer, Hieu Tri Nim, Mandana Nikpour, Ying B Sun, Amy Kao, Oliver Guenther, Eric Morand, Alberta Hoi
Original research: Clinical impact of hydroxychloroquine dose adjustment according to the American Academy of Ophthalmology guidelines in systemic lupus erythematosus (19 May, 2020)
Ileana Vázquez-Otero, Nicolle Medina-Cintrón, Mariangelí Arroyo-Ávila, Lorena González-Sepúlveda, Luis M Vilá
Original research: Real-world treatment patterns, healthcare resource utilisation and costs in patients with systemic lupus erythematosus treated with belimumab: a retrospective analysis of claims data in the USA (26 March, 2020)
Christopher F Bell, Julie Priest, Marni Stott-Miller, Hong Kan, Justyna Amelio, Xue Song, Brendan Limone, Virginia Noxon, Karen H Costenbader
Original research: Utility of the AVISE Connective Tissue Disease test in predicting lupus diagnosis and progression (18 March, 2020)
Emily Liang, Mihaela Taylor, Maureen McMahon
Original research: Serum uric acid is associated with damage in patients with systemic lupus erythematosus (5 February, 2020)
Claudia Elera-Fitzcarrald, Cristina Reátegui-Sokolova, Rocio Violeta Gamboa-Cardenas, Mariela Medina, Francisco Zevallos, Victor Román Pimentel-Quiroz, Jorge Mariano Cucho-Venegas, José Alfaro-Lozano, Zoila Rodriguez-Bellido, Cesar Augusto Pastor-Asurza, Risto Alfredo Perich-Campos, Graciela S Alarcón, Manuel Francisco Ugarte-Gil

Immunology and inflammation

Original research: Lupus serum induces inflammatory interaction with neutrophils in human glomerular endothelial cells (9 October, 2020)
Dayvia A Russell, Margaret Markiewicz, Jim C Oates
Original research: Neutrophil and lymphocyte counts are associated with different immunopathological mechanisms in systemic lupus erythematosus (21 May, 2020)
Bobby Kwanghoon Han, Katherine D Wysham, Kevin C Cain, Helena Tyden, Anders A Bengtsson, Christian Lood

Letter

Could severe COVID-19 be considered a complementopathy? (19 May, 2020)
Katerina Chatzidionysiou, Elisabet Svenungsson, Francesca Faustini
Jaccoud-type lupus arthropathy: practical classification criteria (10 May, 2020)
Mittermayer Santiago
Impact of COVID-19 pandemic on SLE: beyond the risk of infection (5 May, 2020)
Alice Horisberger, Laura Moi, Camillo Ribi, Denis Comte
Thoughts on COVID-19 and autoimmune diseases (3 April, 2020)
Anca D Askanase, Leila Khalili, Jill P Buyon

Lupus nephritis

Original research: Multicentre retrospective cohort study assessing the incidence of serious infections in patients with lupus nephritis, compared with non-renal systemic lupus erythematosus (22 September, 2020)
Drew Joseph Yates, Saw Yu Mon, Yumi Oh, Satomi Okano, Valli Manickam, Muriel Soden, Paul Kubler, Dwarakanathan Ranganathan

Protocol

Acthar Gel (repository corticotropin injection) for persistently active SLE: study design and baseline characteristics from a multicentre, randomised, double-blind, placebo-controlled trial (21 April, 2020)
Anca D Askanase, Enxu Zhao, Julie Zhu, Erin Connolly-Strong, Richard A Furie

Reproductive health and APS

Original research: Anti-Müllerian hormone in African-American women with systemic lupus erythematosus (1 November, 2020)
Meghan Angley, Jessica B Spencer, S Sam Lim, Penelope P Howards

Review

Towards a practical management of fatigue in systemic lupus erythematosus (19 November, 2020)
Philippe Mertz, Aurélien Schlencker, Matthias Schneider, Pierre-Edouard Gavand, Thierry Martin, Laurent Arnaud
TNIP1/ABIN1 and lupus nephritis: review
(29 October, 2020)
Makayla P Brady, Erik A Korte, Dawn J Caster, David W Powell
Candidate drug replacements for quinacrine in cutaneous lupus erythematosus (20 October, 2020)
Daisy Yan, Robert Borucki, Richard D Sontheimer, Victoria P Werth
Generating evidence to inform health technology assessment of treatments for SLE: a systematic review of decision-analytic model-based economic evaluations (28 July, 2020)
Sean Gavan, Ian Bruce, Katherine Payne
Outcomes of pregnancy and associated factors in sub-Saharan African women with systemic lupus erythematosus: a scoping review (14 June, 2020)
Mickael Essouma, Jan René Nkeck, Kodoume Motolouze, Jean Joel Bigna, Paul Tchaptchet, Grâce Anita Nkoro, Stéphane Ralandison, Eric Hachulla
Prediction of prognosis and renal outcome in lupus nephritis (18 February, 2020)
Ioannis Parodis, Farah Tamirou, Frédéric A Houssiau
Finding lupus in the ANA haystack (2 February, 2020)
Nancy J Olsen, David R Karp

Main menu

Table of contents

2020 - Volume 7 - 1

Editorial

Animal models

Brief communication

Biomarker studies

Clinical trials and drug discovery

Cutaneous lupus

Co-morbidities

Dialogue

Epidemiology and outcomes

Immunology and inflammation

Letter

Lupus nephritis

Protocol

Reproductive health and APS

Review

Correction

Log in using your username and password

Main menu

Log in using your username and password

You are here

Table of contents

2020 - Volume 7 - 1

Editorial

Animal models

Brief communication

Biomarker studies

Clinical trials and drug discovery

Cutaneous lupus

Co-morbidities

Dialogue

Epidemiology and outcomes

Immunology and inflammation

Letter

Lupus nephritis

Protocol

Reproductive health and APS

Review

Correction